AMH: When Low Really Does Mean Low
POI, Significant Diminished Reserve, and How Endometriosis Fits In
In this issue:
When a very low AMH genuinely changes the plan
How POI and “significant diminished reserve” show up in real life
Why endometriosis (and its surgeries) can pull AMH down faster
What to actually do if your AMH is very low for your age
In the first AMH issue, I asked you to retire the idea of AMH as an egg‑timer.
No straight low‑to‑high relationship with who does and doesn’t get pregnant, unless it’s very low or very high.
Here we look at AMH in the “very low for age” band, where the number actually can materially influence the plan, because it’s part of a bigger pattern that points to premature ovarian insufficiency (POI) or significant damage to the ovaries.
We’re talking roughly under 5–8 pmol/L in Australia and the UK, or about 0.7–1.1 ng/mL in the US.
Not a slightly‑low 8 pmol/L at the age of 36 with clockwork cycles.
The “this is unusually low for 30–32, and the rest of your labs and history agree” kind of low.
When AMH is sitting in that very‑low‑for‑age band and the rest of the picture is also leaning hard in the same direction, it deserves proper attention.
Patterns that make me pay attention:
Very low AMH for age plus rising FSH (often >10–15 IU/L) and irregular or absent periods.
Very low AMH plus a strong family history of early menopause (before 40).
Very low AMH after chemo, pelvic radiation, or major ovarian surgery.
Very low AMH in the context of significant endometriosis, especially endometriomas (ovarian “chocolate cysts” filled with old blood and endometrial‑type tissue).
In those scenarios, AMH is less about vague “fertility potential” and more about flagging that the ovarian reserve is significantly reduced or under direct strain.
Here’s a couple of scenarios to give you the picture.
Scenario 1: Early‑30s, Irregular Cycles & a Very Low AMH
She’s 32.
Her cycles have gone from “a bit variable” to “every second or third month if I’m lucky.”
Her AMH comes back at 3 pmol/L (Aust/UK) - about 0.4 ng/mL (US).
Her FSH is up in the mid‑teens, twice, a few weeks apart.
Her mum hit menopause at 39; one aunt had “early change” in her mid‑30s.
This is classic “we need to think about premature ovarian insufficiency” territory.
POI is diagnosed based on symptoms, cycle pattern and repeatedly high FSH, but AMH tends to sit very low or undetectable in this picture and helps document what’s really happening.
In this case you want to:
Have a proper POI work‑up: this usually means a karyotype (a chromosome study to look for missing or rearranged pieces on the X that can drive early ovarian insufficiency), autoimmune screening, coeliac and thyroid testing, and fragile X premutation testing (looking for a change in the FMR1 gene that can be linked to early ovarian insufficiency) where indicated.
Have a grounded conversation about time: not “no chance,” because spontaneous ovulations and pregnancies still happen in POI, but “your window is likely shorter than average.”
Consider your options: trying for pregnancy now rather than “in a few years”, egg or embryo freezing if there is still enough activity to attempt it, and, when needed, early, kind donor‑egg conversations.
In this scenario you want to respect the cluster of signals and not waste time.
Scenario 2: Endometriosis, Surgery & a Diminishing Reserve
She’s 34 with known stage III–IV endometriosis.
She has a 4 cm endometrioma on one ovary, a history of a previous cystectomy in her 20s, and pain that has crept back in.
Her AMH is 5 pmol/L.
Her cycles are still mostly monthly, but lighter.
Women with endometriomas and moderate–severe endometriosis have lower AMH and a faster decline over time than age‑matched controls, even before anyone touches the ovary.
Surgery, especially repeat or bilateral cystectomy, can reduce AMH further and accelerate the drop in ovarian reserve, particularly when baseline AMH is already low.
So here, AMH is not a generic “you’re getting old.”
It is part of documenting ovarian damage and risk to future reserve.
In this case you want to:
Have a deliberate conversation with the gynaecologist and fertility specialist about timing: do we complete family‑building before more surgery, or at least bank eggs/embryos first.
Have a surgical strategy that is as conservative as safely possible for the ovary: careful technique, thinking hard before repeat or bilateral cystectomy, and acknowledging that “cleaning everything up” has a cost.
Focus on working on the inflammatory, immune and metabolic drivers of endometriosis, so surgery is not the only lever you pull.
Again, the number is not the whole story. It is one of the few objective measures we have of how much functional ovary is left in an ovary that has already taken hits.
What To Do With a Truly Low Result
This is where to use the number to focus your mind on decisions.
Shorten the decision horizon. If you want a baby, we talk about trying sooner rather than “someday,” because biology is already moving.
Get the right people in the room: a fertility specialist who understands POI or endometriosis, not just generic “unexplained infertility.”
Consider banking what’s bankable (eggs or embryos) if there is still enough ovarian activity to make that worthwhile.
Do the basics which are nonetheless powerful, that support whatever ovarian function remains: blood sugar, thyroid, micronutrients, inflammation, sleep, medications and supplements that actually fit your picture.
And do keep one more fact on the table: even in POI, ovaries can and do have spontaneous, unpredictable bursts of activity.
Pregnancies happen.
You deserve information that is sharp and honest enough to change your plan when it needs changing, without erasing the part of the story that is still open.
Warmly, Sonja
New Here? Head to the About & Welcome pages for why I started Baby Ready Health and a bit about me.
Issues are free for now. If you’re someone who likes to build things early, you can become a founding member. Or simply subscribe and follow along.
This post is for educational purposes only and is not medical advice. Always consult a qualified practitioner before making decisions about your health.
References:
Huang Y, Kuang X, Jiangzhou H, Li M, Yang D, Lai D. Using anti-Mullerian hormone to predict premature ovarian insufficiency: a retrospective cross-sectional study. Front Endocrinol (Lausanne). 2024;15:1454802. https://doi.org/10.3389/fendo.2024.1454802
Hunter JE, Epstein MP, Tinker SW, Charen KH, Sherman SL. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity. Genet Epidemiol. 2008;32(6):553-559. https://doi.org/10.1002/gepi.20329
Hwu YM, Wu FS, Li SH, Sun FJ, Lin MH, Lee RK. The impact of endometrioma and laparoscopic cystectomy on serum anti-Mullerian hormone levels. Reprod Biol Endocrinol. 2011;9:80. https://doi.org/10.1186/1477-7827-9-80
Magraith K, Wong J. Premature ovarian insufficiency and infertility. Aust J Gen Pract. 2023;52(1-2):26-31. https://www1.racgp.org.au/ajgp/2023/january-february/premature-ovarian-insufficiency-and-infertility